XML 57 R12.htm IDEA: XBRL DOCUMENT

6. SHARE-BASED COMPENSATION

12 Months Ended

Dec. 31, 2019

Share-based Payment Arrangement [Abstract]

NOTE 6: SHARE-BASED COMPENSATION

The following table summarizes the activity of our nonvested restricted shares for the years ended December 31, 2019 and 2018:

	Restricted Shares			Weighted-Average Grant-Date Fair Value
Nonvested at December 31, 2017		250		$	0.50
Granted		300			0.79
Vested		(120	)		0.83
Nonvested at December 31, 2018		430		$	0.83
Granted		200			0.65
Vested		(160	)		0.73
Nonvested at December 31, 2019		470		$	0.83

The following table summarizes the activity of our nonvested stock options for the years ended December 31, 2019 and 2018:

	Shares Underlying Options		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in years)
Outstanding at December 31, 2018		–	$	–		–
Granted		300	$	0.70		4.6
Cancellations & Forfeitures		–	$	0.70		–
Outstanding at December 31, 2019		300	$	0.70		4.6
Exercisable at December 31, 2019		75	$	0.70		4.6

For the years ended December 31, 2019 and 2018, we recognized a total of $250 and $56, respectively, of share-based compensation expense related to restricted stock awards and stock options, which is included in selling, general and administrative expenses in the accompanying consolidated statements of operations. The unamortized estimated fair value of nonvested shares of restricted stock awards and stock options was $134 and $222 at December 31, 2019 and 2018, respectively. These costs are expected to be recognized as expense over a weighted-average period of 2.06 years.